Test Code GTT Glucose Tolerance Test
Additional Codes
GL50
GT2
GTT3
GT4
GT5
GTT6
Clinical Significance
Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma. Oral glucose tolerance tests are performed to establish a diagnosis:
- In patients with transient or sustained glucosuria who have no clinical symptoms of diabetes (polyuria) and with normal fasting and postprandial blood glucose levels.
- In patients with symptoms of diabetes but with no glucosuria and normal fasting levels.
- In persons with a strong family history of diabetes, but with no overt symptoms.
- In patients whose glucosuria is associated with pregnancy, thyrotoxicosis, liver disease, and/or infections.
- In women who have characteristically large (>4000 gm) babies.
- In patients with neuropathies and retinopathies of undetermined origin.
Patients with mild or diet-controlled diabetes may have fasting blood glucose levels within the normal range, but be unable to produce sufficient insulin for prompt metabolism of ingested carbohydrate. As a result, blood glucose rises to abnormally high levels and the return to normal is delayed. In other words, the patient has a decreased tolerance for glucose. Therefore, glucose tolerance tests are most helpful in establishing a diagnosis of a mild case of diabetes.
When a standard dose of 100 grams of glucose is given orally, absorption occurs rapidly and the blood glucose concentration increases. In a normal patient, this stimulates the pancreas to produce more insulin with the result that after 30 to 60 minutes the blood level of glucose begins to decrease. Since there now exists more insulin than necessary, the blood glucose tends to drop below the fasting level after 1.5 to 2 hours, and then returns to normal levels around 3 hours. Response to glucose in various conditions is shown with a glucose tolerance curve.
In a normal response the fasting level of serum glucose is within normal limits, the peak concentration is reached 30 to 60 minutes and does not exceed 170 mg/dL. If the values in the first hour show a rapid fall to normal values or a flat curve with no appreciable rise usually reflect primary alterations in intestinal absorptive states. A very flat rise in blood glucose followed by a prolonged and pronounced hypoglycemic phase may be observed in primary and secondary hyperinsulinism.
Methodology
Oxygen rate method (Beckman Coulter UniCel DxC 660i)
Special Instructions
GL50 - Patient does not have to be fasting, 50g glucose dose is given and sample is drawn at 1 hour.
GT2 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 75g glucose dose and drawn 2 hours later.
GTT3 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 100g glucose dose and drawn at 30 minutes, 1, 2, and 3 hours.
GT4 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 100g glucose dose and drawn at 30 minutes, 1, 2, 3, and 4 hours.
GTT6 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 100g glucose dose and drawn at 30 minutes, 1, 2, 3, 4, 5 and 6 hours.
Note: For children it is 1.75g per kg of body weight. Remove excess drink to equal correct concentration.
Sample Type
Preferred Sample Type | |
---|---|
Light green top - Plasma |
Acceptable Sample Type(s) | |
---|---|
Yellow top - Serum |
Centrifuge: Yes
Specimen Minimum Volume
0.5 mL
Specimen Stability
Temperature | Time |
---|---|
Ambient (18-25°C) | 8 hours |
Refrigerated (2-8°C) (store) | 48 hours |
Frozen (-15 to -20°C) | 1 month |
Separate plasma or serum from cells within 2 hours.
Reference Ranges
Normal Ranges | ||
---|---|---|
Sample Interval | Age | Units (mg/dL) |
Fasting | <1 month | 40 - 90 |
>1 month | 60 - 100 |
Test | Sample Interval | Units (mg/dL) |
GL50* | 1 hour | <140 |
GT2 | 2 hours | <155 |
GT3 | 30 minutes | 110 - 170 |
1 hour | <180 | |
2 hours | <155 | |
3 hours | <140 | |
GT4 | 30 minutes | 110 - 170 |
1 hour | <180 | |
2 hours | <155 | |
3 hours | <140 | |
4 hours | Not established | |
GTT6 | 30 minutes | 110 - 170 |
1 hour | <180 | |
2 hours | <155 | |
3 hours | <140 | |
4 hours | Not established | |
5 hours | Not established | |
6 hours | Not established |
*Patient does not need to be fasting. Baseline sample not collected.
Critical Values | ||
---|---|---|
Sample Interval | Age | Units (mg/dL) |
Fasting** | <1 month | <30 or >299 |
>1 month | <51 or >499 |
**If the fasting glucose is above 200 mg/dL, the ordering physician should be notified immediately. If testing is to proceed a pathologist should be consulted for approval.
Technical Range | |
---|---|
10 - 2,000 mg/dL |
Rejection Criteria
Hemolysis | N/A |
---|---|
Icterus | N/A |
Lipemia | 3+ or greater, ultracentrifuge |
Availability
Performed | STAT |
---|---|
24/7 | No |
Performing Laboratory
MulltiCare Yakima Memorial Hospital Laboratory
Lab Department
Chemistry
CPT Code
GL50 82947
GT2 82947 (x2)
GT3 82951 + 82952 (x2)
GT4 82951 + 82952 (x3)
GTT6 82951 + 82952 (x5)
LOINC
1547-9 Glucose baseline [Mass/Vol]
1558-6 Glucose post fast [Mass/Vol]
20439-6 Glucose 30 Min post dose glucose [Mass/Vol]
20438-8 Glucose 1 Hr post dose glucose [Mass/Vol]
20436-2 Glucose 2 Hr post dose glucose [Mass/Vol]
20437-0 Glucose 3 Hr post dose glucose [Mass/Vol]
26541-3 Glucose 4 Hr post dose glucose [Mass/Vol]
26543-9 Glucose 5 Hr post dose glucose [Mass/Vol]
26544-7 Glucose 6 Hr post dose glucose [Mass/Vol]